Document is current
Any future updates will be listed below
-
Authors
Bongiovanni, Tindaro
Santiago, Marina
Zielinska, Kinga
Scheiman, Jonathan
Barsa, Carolina
Jäger, Ralf
Pinto, Daniela
Rinaldi, Fabio
Giuliani, Giammaria
Senatore, Tullio
Kostic, Aleksandar D.
- License Information
-
More Information
Article History
Received: 30 May 2023
Accepted: 18 September 2024
First Online: 2 January 2025
Declarations
:
: The open-label study was a consumer research study, and all participants signed an informed consent form. The experimental protocol for the controlled longitudinal study was approved by the Ethical Independent Committee for Clinical, not pharmacological investigation in Genoa (Italy) and followed the ethical standards of the 1964 Declaration of Helsinki (Rif. 2020/12). All participants signed an informed consent form.
: Not applicable.
: MS, KZ, RJ, and AK are consultants of FitBiomics, Inc. JS is an employee and shareholder of FitBiomics, Inc. DP, FR, and GG are employees of Giuliani Pharmaceuticals. FR serves as a consultant for Giuliani SpA. GG is on the board of directors of Giuliani SpA.
